Strengths

● Thanks to a sound financial situation, the firm has significant leeway for investment.

● Sales forecast by analysts have been recently revised upwards.

● For the past twelve months, EPS forecast has been revised upwards.

● For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.

● The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.


Weaknesses

● Technically, the stock approaches a strong medium-term resistance at EUR 23.84.

● Low profitability weakens the company.

● Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.

● Based on current prices, the company has particularly high valuation levels.

● With an expected P/E ratio at 47.92 and -38.52 respectively for both the current and next fiscal years, the company operates with high earnings multiples.

● For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.

● Below the resistance at 25 EUR, the stock shows a negative configuration when looking looking at the weekly chart.